Diabetes (Type 1 & Type 2)
Diabetes mellitus is a group of metabolic diseases characterized by high blood sugar levels. Type 1 diabetes is an autoimmune condition where the immune system destroys insulin-producing beta cells. Type 2 diabetes involves insulin resistance and relative insulin deficiency. Both types can lead to serious complications affecting the heart, kidneys, eyes, and nerves.
Prevalence
Diabetes affects approximately 37 million Americans (about 11% of the population). About 5-10% have Type 1, and 90-95% have Type 2. An additional 96 million have prediabetes.
Who It Affects
Type 1 typically develops in children and young adults but can occur at any age. Type 2 risk factors include obesity, family history, age over 45, sedentary lifestyle, and certain ethnicities (African American, Hispanic, Native American).
Important: This information is for educational purposes only and does not constitute medical advice. Regenerative therapies are investigational and not FDA-approved to treat this condition.
Common Symptoms
Common Causes & Risk Factors
Traditional Treatment Options
Insulin Therapy
Essential for Type 1; increasingly used in Type 2 as disease progresses.
Limitations: Requires multiple daily injections or pump. Risk of hypoglycemia. Doesn't address underlying cause.
Oral Medications
Multiple classes for Type 2 (metformin, sulfonylureas, SGLT2 inhibitors, GLP-1 agonists).
Limitations: May lose effectiveness over time. Side effects vary by medication class.
GLP-1 Receptor Agonists
Injectable medications that improve blood sugar and promote weight loss.
Limitations: Expensive. GI side effects common. Requires injection.
Lifestyle Modifications
Diet, exercise, and weight loss—cornerstone of Type 2 management.
Limitations: Requires significant, sustained lifestyle changes. May not be sufficient alone.
Pancreas/Islet Transplant
For select Type 1 patients; provides insulin independence.
Limitations: Limited donor organs. Requires immunosuppression. Usually for severe cases.
Regenerative Medicine Approach
How Regenerative Therapy May Help
Regenerative medicine for diabetes is an active area of research, particularly for Type 1. Scientists are exploring whether stem cells can be used to create new insulin-producing beta cells or to modulate the autoimmune response. Research for Type 2 focuses on potential metabolic improvements.
Potential Benefits Being Studied:
- Type 1: Research on creating new insulin-producing cells
- Type 1: Studying immunomodulation to protect remaining beta cells
- Type 2: Exploring potential metabolic effects
- Some clinical trials showing reduced insulin requirements
- Very active area of research with multiple approaches
- Does not replace current diabetes management
Biologics Used:
Mesenchymal stem cells in clinical trials
Islet-like cells derived from stem cells (research)
Exosomes being studied for metabolic effects
Frequently Asked Questions
Can stem cells cure Type 1 diabetes?
Not yet. Research is promising—scientists can now create insulin-producing cells in the lab—but challenges remain including protecting these cells from immune attack. Clinical trials are ongoing but no cure is available yet.
What about Type 2 diabetes?
For Type 2, lifestyle changes and medications are effective for most patients. Regenerative therapy research for Type 2 is less advanced. Weight loss (including bariatric surgery for some) can put Type 2 into remission.
Should I stop my insulin or medications?
Never stop diabetes medications without physician guidance. Uncontrolled diabetes causes serious complications. Any experimental therapy would be closely monitored with standard treatment continued.
Ready to Explore Your Options?
Schedule a free consultation to discuss diabetes (type 1 & type 2) and learn if regenerative medicine may be right for you.
Important Disclaimer
Regenerative therapies for diabetes are investigational and not FDA-approved. Diabetes requires ongoing management by an endocrinologist. Never stop prescribed medications. Research is promising but no cure is available yet.